Endovascular Acute Stroke Intervention - Tandem OCclusion Trial

Recruiting N/A Interventional Study
Stroke, Acute Carotid Stenosis Carotid Artery Diseases
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
458 (estimated)
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Patients with tandem occlusion or tandem lesion (TL), that is, stroke with an acute intracranial anterior circulation occlusion and an ipsilateral cervical ICA (c-ICA) high-grade stenosis or occlusion, constitute about 15-20% of patients undergoing endovascular thrombectomy (EVT). However, the optimal treatment of acute stroke patients with TL remains uncertain, as relatively few patients with TL…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Acute ischemic anterior circulation stroke eligible for endovascular therapy according to local guidelines, with or without prior intravenous thrombolysis: * Occlusion of the carotid terminus, M1 or M2 segments of the middle cerebral artery (MCA) * A neurological deficit …
Contacts

Alexandre Y Poppe, MD CM

5148908000

alexandre.poppe.med@ssss.gouv.qc.ca

CONTACT

Imene Fahmi, MSc

5148908000

easitoc.chum@ssss.gouv.qc.ca

CONTACT